The scavenger receptor cysteine-rich (SRCR) proteins form an archaic group of metazoan proteins characterized by the presence of SRCR domains. These proteins are classified in group A and B based on the number of conserved cysteine residues in their SRCR domains, i.e. six for group A and eight for group B. The protein DMBT1 (deleted in malignant brain tumors 1), which is identical to salivary agglutinin and lung gp-340, belongs to the group B SRCR proteins and is considered to be involved in tumor suppression and host defense by pathogen binding. In a previous study we used nonoverlapping synthetic peptides covering the SRCR consensus sequence to identify a 16-amino acid bacteriabinding protein loop (peptide SRCRP2; QGRVEVLYRG-SWGTVC) within the SRCR domains. In this study, using overlapping peptides, we pinpointed the minimal bacteria-binding site on SRCRP2, and thus DMBT1, to an 11-amino acid motif (DMBT1 pathogen-binding site 1 or DMBT1pbs1; GRVEVLYRGSW). An alanine substitution scan revealed that VEVL and Trp are critical residues in this motif. Bacteria binding by DMBT1pbs1 was different from the bacteria binding by the macrophage receptor MARCO in which an RXR motif was critical. In addition, the homologous consensus sequences of a number of SRCR proteins were synthesized and tested for bacteria binding. Only consensus sequences of DMBT1 orthologues bound bacteria by this motif.
creted proteins that are characterized by the presence of one or more SRCR domains. SRCR domains consist of ϳ110 amino acids and are divided into groups A and B based on the number of conserved cysteine residues, namely six for group A and eight for group B.
The best studied members of the group A SRCR proteins are the macrophage scavenger receptor (MSR1), the Mac 2-binding protein (Mac-2bp), and MARCO. Both MSR1 and MARCO are known to interact with bacteria (6, 7) . In contrast to MARCO (8) , the SRCR domain of MSR1 does not seem to be involved in bacteria binding (9, 10) . Bacteria binding by MARCO involves an RXR motif within the SRCR domain, indicating that ionic interactions play a crucial role in the interaction with its negatively charged ligands (6) .
Group B SRCR proteins are generally involved in the regulation of cellular immune responses. In vertebrates, the group B SRCR proteins can be divided, on the basis of their structure and sequence homology, into three subgroups (11) . The first subgroup includes CD5 (12) , CD6 (13) , and SP␣ (14) . CD5 and CD6 are composed of an extracellular region of three SRCR domains, a transmembrane region, and a cytoplasmic region. SP␣ lacks the latter two regions but contains three SRCR domains that are highly homologous to those of CD5 and CD6. These three proteins are mainly expressed by T-cells and Bcells (12, 13) . The second subgroup of SRCR group B molecules is the workshop cluster 1 (WC1) family, which includes WC1, CD163, and M160 (11, 15) . These molecules are primarily related to monocyte and macrophage cell lineages. CD163 scavenges haptoglobin-hemoglobin complexes (16) . The third subgroup of group B SRCR proteins includes human DMBT1 (deleted in malignant brain tumors 1) (17) (18) (19) (20) (21) (22) with homologues in the rat (Ebnerin) (23) , mouse (CRP-ductin) (24) , rabbit (Hensin) (25) , and cow (bovine gallbladder mucin) (26) . Pema-SRCR from the sea lamprey Pertromyzon marinus (27) is also included in this subgroup. Molecules of this subgroup are expressed by epithelial cells in the gastrointestinal tract and the ducts of the exocrine glands and are commonly secreted in mucosal fluids (28) . They are associated with host defense, e.g. by pathogen binding, but also have been suggested as playing a role in epithelial differentiation (27) .
Salivary agglutinin and lung gp-340 are encoded by the gene DMBT1 on chromosome 10q25.3-q26.1 (18, 20, 22, 29, 30) . These proteins represent the DMBT1 isoforms secreted in the saliva (DMBT1 SAG ) and the lung fluid (DMBT1 GP340 ), respectively. For about two decades DMBT1 SAG , which manifests a broad bacteria binding spectrum, has been intensively investigated with regard to its role in caries prevention by binding and agglutination of cariogenic bacteria in the oral cavity (31, 32) . DMBT1 GP340 is putatively involved in respiratory tract protection because it interacts with the defense collectin surfactant proteins D (SP-D) and A (SP-A) and is able to stimulate alveolar macrophage migration (18, 33) .
By initial protein digestion and utilization of non-overlapping synthetic peptides, we recently identified a protein loop in the SRCR domains of DMBT1 that was able to bind to various bacteria (16) . The use of synthetic peptides thus offered us a simple in vitro system to explore fundamental aspects of DMBT1-and SRCR-mediated bacteria binding in general.
In this study we have defined the minimal bacteria-binding motif on DMBT1 as an 11-mer peptide designated DMBT1pbs1 (DMBT1 pathogen-binding site 1). By an alanine substitution scan, critical amino acid residues within this motif were identified. Consensus peptides were derived from the DMBT1pbs1-corresponding regions of other SRCR proteins. Only the peptides derived from DMBT1 and its orthologues showed significant bacterial binding.
EXPERIMENTAL PROCEDURES

Purification of DMBT1
SAG -DMBT1
SAG was purified by gel filtration as described previously (29) . DMBT1 SAG was eluted from a Sephacryl S-400 HR column (Amersham Biosciences) with either phosphate-buffered saline or Tris-buffered saline (10 mM Tris-HCl and 150 mM NaCl, pH 7.4). Peptide Design, Synthesis, and Purification-All synthetic peptides were SRCR domain consensus-based and designed as described previously using alignment software (DNASTAR, Lasergene Inc., Madison, WI) (17) . For determination of the minimal bacteria binding site we synthesized overlapping 16-mer peptides covering the SRCR consensus sequence ranging from six amino acids toward the amino terminus (peptide SRCRP ϩ 6N) to six amino acids toward the carboxyl-terminus (SRCRP2 ϩ 6C), relative to SRCRP2. To study the role of the individual amino acids in pathogen binding, we synthesized a set of peptides in which each residue, in its turn, was substituted for alanine (alanine substitution scan). To identify corresponding sequences in other SRCR proteins, the Pfam data base (www.sanger.ac.uk/Software/Pfam/index. shtml) was searched using "SRCR" or the Protein Data Bank accession code "1BY2" as the key word, which led us to the SRCR superfamily data base. Consensus sequences of the SRCR domains in these proteins were calculated with DNAstar (17) .
Bacteria-Streptococcus mutans
Solid phase synthesis by Fmoc (N-(9-fluorenyl)methoxycarbonyl)
FIG. 1. Determination of the minimal binding sequence within the SRCR consensus sequence of DMBT1.
A, based on the SRCR consensus sequence of DMBT1, overlapping synthetic 16-mer peptides were designed and synthesized, extending six residues amino-and carboxyl-terminal of SRCRP2. *, peptides possessing bacterial agglutination activity. B, bacteria binding properties of peptides tested in adhesion and agglutination assays. Peptides SRCRP2 ϩ 4N to SRCRP2 ϩ 1C bound S. mutans in the adhesion assay. Fluorescence is a measure for bacterial binding. Error bars represent the S.E. The bacterial agglutination assay confirmed the results of the adhesion assay (black bars, agglutination; white bars, no agglutination). C, the homologous sequence shared by the bacteria binding peptides (GRVEVLYRGSW) was synthesized and tested for bacteria binding in the adhesion and aggregation assays. This peptide is the smallest peptide showing bacteria binding. Amino-terminal and carboxy-terminal truncated peptides did not show bacteria binding.
chemistry was performed with a MilliGen 9050 peptide synthesizer (MilliGen/Biosearch, Bedford, MA), as described previously. After purification, the purity of these peptides was Ͼ90% (17) . The authenticity of the peptides was confirmed by quadrupole-time of flight mass spectrometry on a tandem mass spectrometer (Micromass Inc., Manchester, United Kingdom) as described previously (34) . The peptides used in the experiments of Table I were obtained from Eurogentec S.A. (Seraing, Belgium) and had a purity of at least 70%.
Adhesion Assays-Bacterial adhesion was examined using a microtiter plate method based on the labeling of microorganisms with cellpermeable DNA binding probes, as reported earlier (17, 35) . Fluotrac 600 microtiter plates (Greiner, Recklinghausen, Germany) were coated with various amounts of either synthetic peptides or purified DMBT1 SAG . The peptides were dissolved in coating buffer (100 mM sodium carbonate, pH 9.6) to a starting concentration of 40 g/ml and 2-fold serially diluted. After incubation at 4°C for 16 h, the plates were washed twice with the relevant buffers. Subsequently, 100 l of a bacterial suspension (5 ϫ 10 8 bacteria/ml TTC) were added to each well and incubated at 37°C for 2 h. Plates were washed three times with the same buffer using a plate washer (Mikrotek EL 403, Winooski, VT). Bound bacteria were detected using 100 l/well SYTO-9 solution (1 mM) (Molecular Probes), a cell permeating and DNA-binding fluorescent probe. Plates were incubated in the dark at the ambient temperature for 15 min and washed three times with the same buffer. Fluorescence was measured in a Fluostar Galaxy microtiter plate fluorescence reader (BMG Laboratories, Offenburg, Germany) at 488-nm excitation and 509-nm emission wavelengths. These experiments were repeated at least three times.
Agglutination Assays-100 l of a bacterial suspension (5 ϫ 10 8 bacteria/ml) were mixed with 20 l of peptide solution at final peptide concentrations of 0 -200 g/ml in 48-well microtiter plates (Falcon, Piscataway, NJ) and incubated at 37°C for 5-15 min. Agglutination was scored visually. Turbidimetric analysis of the agglutination process was carried out with a UVICON 930 spectrophotometer (Kontron Instruments, Watford, United Kingdom) using 150 M peptide as described earlier (17) . The optical densities of the bacterial suspensions were monitored at 700 nm at 37°C for 60 min. These experiments were repeated at least three times.
RESULTS
Determination of the Minimal Pathogen-binding Site of DMBT1-We
have defined the precise binding site within SRCRP2 by testing the bacteria binding properties of a set of sequentially overlapping 16-mer peptides extending from residues 12-27 to 24 -39 (SRCRP2 ϩ 6N to SRCRP2 ϩ 6C) of the SRCR domain consensus sequence (Fig. 1A) . Only peptides 14 -29 and 19 -34 (SRCRP2 ϩ 4N to SRCRP2 ϩ C1) bound bacteria in the adhesion assay (Fig. 1B) . Peptide 19 -29, representing the shared motif within these peptides ( 19 GRVEV-LYRGSW 29 ), also bound to bacteria and was further referred to as DMBT1pbs1. Further truncation of this motif, either at the amino or the carboxyl terminus, yielded peptides without bacteria binding properties (Fig. 1C) . Like SRCRP2 and the native DMBT1, DMBT1pbs1 bound to Gram-positive (S. mutans and S. gordonii) as well as to Gram-negative bacteria (E. coli and H. pylori) (Fig. 2B) . With SRCRP2, the agglutination of S. mutans was observed after ϳ30 min, whereas with the corresponding concentrations of DMBT1pbs1 the agglutination of S. mutans was already observed after 2-3 min (Fig. 2) .
Determination of Essential Amino Acid Residues in DMBT1pbs1-To determine key residues in DMBT1pbs1 required for bacteria binding, a full alanine substitution scan was performed. A set of peptides was synthesized in which each residue across the DMBT1pbs1 peptide, in its turn, was substituted for alanine. This peptide set was tested in the adhesion assay (Fig. 3) . Binding to S. mutans was strongly reduced by substitution of Val-3, Glu-4, Val-5, Leu-6, and Trp-11 (Fig. 3) . Agglutination assays (not shown) confirmed the results of the adhesion assays.
The Motif in the Carboxyl-terminal SRCR Domain of DMBT1 Is Functionally Distinct-The DMBT1pbs1 peptide is present in 10 of the 14 SRCR domains of DMBT1. To investigate the bacteria binding of the motifs present within the four remaining SRCR domains, the corresponding peptides were synthesized and tested. Only the SRCR14 peptide, in which five residues are different from the consensus sequence, did not bind to bacteria (Table I) .
Analysis of the Bacteria Binding Features of Motifs Present within Other Members of the SRCR Superfamily-Because
SRCR domains are highly conserved across species, we investigated whether DMBT1pbs1-corresponding sequences in other SRCR proteins also exhibited bacteria binding. Using the Pfam (protein family) data base, 85 SRCR proteins were found containing altogether 301 SRCR domains. For each protein, the consensus sequence of its SRCR domains was determined, and the motif corresponding to DMBT1pbs1 was synthesized. In this way a representative number of 11-mer peptides covering the consensus sequences of 20 different SRCR proteins were tested for bacteria binding. Only the peptides derived from DMBT1 and DMBT1 orthologues such as mouse CRP-ductin, the rat Ebnerin, the rabbit Hensin, and the bovine gallbladder mucin, bound bacteria (Table I) . DISCUSSION In the present study we determined the minimal bacteriabinding site of DMBT1 and examined whether corresponding domains in other SRCR proteins also exhibit bacteria binding. By testing a set of overlapping peptides, the minimal bacteriabinding site was pinpointed as an 11-amino acid sequence, GRVEVLYRGSW, designated DMBT1pbs1. Alanine substitution of Val-3, Glu-4, Val-5, Leu-6, and Trp-11 resulted in a drastic decrease of bacteria binding. These residues are highly conserved within the 14 SRCR domains of DMBT1, the only difference being the presence of Ile-5 in domains 1 and 14. In previous studies, we have found that DMBT1 SAG agglutinated bacteria in a calcium-dependent fashion (17) . We postulate that the critical role of Glu-4 and Trp-11 in bacteria binding reflects the Ca 2ϩ chelation by their side chains. The sensitivity to Ala substitution of the three hydrophobic residues surrounding Glu-4 is less obvious in this model. As these substitutions have little effect on overall hydrophobicity, this sensitivity indicates that a proper fit is required for bacteria binding. This is corroborated by the finding that the replacement of Val-5 by the more similar Ile, as in the SRCR domain 1 peptide, has little if any effect (Table I) .
Analysis of the SRCR consensus domain using sequentially overlapping 16-mer peptides showed that peptides lacking Gly-1 were completely incapable of bacteria binding. Together with the conservation of this residue throughout the SRCR superfamily (Table I) , this finding points to an essential role for this residue. Surprisingly, the substitution of Gly-1 by Ala had no effect. In terms of the above model, this result is explained by assuming that the introduction of a positively charged N terminus at Arg-2 by the omission of Gly-1 would lead to detrimental electronic repulsion.
The absence of binding by the DMBT1pbs1 motif of SRCR domain 14 is not surprising, because this domain shows much less homology (60%) with the other 13 SRCR domains (87-100%) of DMBT1. Also, its location in the molecule within two CUB domains does not support a role in multivalent bacteria binding, which is probably fulfilled by the other SRCR domains.
The DMBT1pbs1 11-mer peptide induced agglutination more rapidly than did the 16-mer SRCRP2 peptide (Fig. 2) . This may be explained by the fact that SRCRP2 has a lower isoelectric point (pI ϭ 8.22) than DMBT1pbs1 (pI ϭ 8.75), resulting in a lower positive charge and thus a decreased affinity for the negatively charged bacterial surface.
The first three amino acids (QGR) of the SRCRP2 16-mer peptide were homologous with the bacteria binding site on the SRCR domain of MARCO (RGR) (6) . Although both bacteria binding sites are located on the SRCR domains of the proteins, the results in this paper suggest different bacteria binding mechanisms. DMBT1pbs1 does not contain the QGR motif, and substitution of Arg-2 in DMBT1pbs1 did not result in the disappearance of binding. The positively charged RXR motif of MARCO suggests an electrostatic interaction with the negatively charged bacterial surface. In DMBT1pbs1, a negatively charged residue (E4) and the hydrophobic residues (Val-3, Val-5, Leu-6, and Trp-11) are important for bacteria binding. 
TABLE I Bacteria binding by DMBT1pbs1 homologous peptides of other SRCR domains
The three DMBT1pbs1 homologues that were not identical with the consensus sequence were synthesized. For a number of SRCR proteins the consensus sequence of its SRCR domains was calculated as described under "Results," and DMBT1pbs1 homologous peptides were synthesized. A and B denote group A and group B SRCR proteins. Binding and agglutination activity of these peptides was tested with S. mutans and E. coli. Only the DMBT1pbs1 peptide of DMBT1 orthologues showed significant bacterial binding and agglutination capacity. Of the SRCR domains of DMBT1, the peptide of domain 14 exerted no bacteria binding. Binding studies with corresponding peptides of other SRCR consensus sequences showed that only highly homologous sequences, such as those present in DMBT1 orthologues, displayed bacteria binding (Table I) . Strikingly, SRCR consensus sequences of some other proteins, including P. marinus Pema-SRCR, bovine WC1, and Plo2 of Perca flavescens, possessed the minimal bacteria binding motif but did not bind to bacteria. These results suggest that, in addition to the presence of the VEVLXXXXW motif, a proper three-dimensional folding of DMBT1pbs1 is quintessential for bacteria binding. For example, the replacement of Arg-8 by Ala will not influence the secondary structure, whereas replacement by Gly as in Pema-SRCR, resulting in a di-glycine motif, may favor the introduction of a ␤-turn. As Pema-SRCR still contains the critical VEVLXXXXW sequence, this observation suggests that Trp must have a proper orientation with respect to the VEVL stretch for bacteria binding. This sensitivity of DMBT1pbs1 to the substitution of seemingly non-critical residues underlines the need for whole proteins to be tested for conclusive results of bacteria binding.
SRCR domains are present in proteins of all Metazoa. We studied the degree of conservation of the amino acids in SRCR domains by using hidden Markov model logos (37) (at logos. molgen.mpg.de/cgi-bin/logomat-m.cgi?pfamid) in combination with the Pfam (protein family) data base (www.sanger.ac. uk/cgi-bin/Pfam/getacc?PF00530). This study revealed that Gly-1, Val-3, Glu-4, Val-5, and Trp-11 of DMBT1pbs1 are highly conserved along the whole SRCR superfamily, suggesting that these residues are important for the structure and function of SRCR domains. Despite the high degree of conservation, bacteria binding was only found for DMBT1 and its orthologues by this motif (Table I) . These results suggest that less conserved residues, which seemed to be non-critical in the alanine substitution scan, were also important for bacteria binding. Because SRCR proteins are usually involved in different kinds of ligand binding (38) , the conserved residues in DMBT1pbs1 may form a general ligand binding motif of SRCR proteins that, in DMBT1 orthologues, has developed into a bacteria binding motif.
After studying the phylogenetic tree of the SRCR superfamily, Holmskov et al. identified P. marinus as the most primitive species with a DMBT1 orthologue (30) . The consensus sequence of this protein possesses the DMBT1pbs1 binding motif, although no binding for this peptide was demonstrated (Table I) . Next to the Pema-SRCR protein, DMBT1 orthologues have only been characterized in Mammalia, for example CRP-ductin/ Vomeroglandin in the mouse, Ebnerin in the rat, Hensin in the rabbit, and bovine gallbladder mucin. It remains to be investigated whether DMBT1 orthologues are present in non-mammalian vertebrates and whether these proteins are involved in bacteria binding in vivo.
In conclusion, we have narrowed down the minimal bacteriabinding site on the SRCR domains of DMBT1 to an 11-mer peptide, GRVEVLYRGSW, and we have identified a number of critical residues within this stretch. Despite considerable sequence similarities in this motif throughout the SRCR superfamily, bacteria binding by this motif is thus far restricted to DMBT1 orthologues.
